TGF-β is a well-known regulator of fibrosis and can recruit cancer-associated fibroblasts to the TME and promote extracellular matrix remodeling, which has been implicated in increased cancer invasion, metastasis, and resistance to anticancer therapy in preclinical studies (59–67). This evidence concerns the gene TGFB1 and cancer.